Document is current
Any future updates will be listed below
-
Authors
Andreassen, Sofus https://orcid.org/0009-0004-9911-5437
Nielsen, Vibe Maria Laden https://orcid.org/0000-0003-2838-9612
Krarup, Anne Lund https://orcid.org/0000-0002-2228-7132
Kamp, Annika
Andersen, Dennis Møller
Krogh-Larsen, Steven
Melgaard, Dorte https://orcid.org/0000-0002-5656-402X
- License Information
-
More Information
Article History
Received: 9 January 2025
Accepted: 28 April 2025
First Online: 20 May 2025
Declarations
:
: The study was registered and approved as a quality study by the hospital administration (ID 2017–011259) and the data safety regulations office (ID K2024-039). All patients consented orally to sedation with Remimazolam, and this was noted on their medical record. In Denmark, a quality study of a clinical treatment with an approved drug does not need written consent, only oral.
: Not applicable.
: The authors declare no competing interests.
